While TET2 ChIPs at the B2M promoter (Supplemental Figure 5C), its loss only weakly reduces B2M expression in B16 cells and does not reduce B2M tumor expression as measured through flow cytometry (Figure 5B), indicating a role for additional actors in promoting B2M gene expression. The gene discussed is B2M; the disease is neoplasm.